Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
Naseema GangatMcCullough KristenIsla JohnsonAref Al-KaliKebede H BegnaMirinal S PatnaikMark R LitzowWilliam HoganMithun Vinod ShahHassan AlkhateebAbhishek A MangaonkarJames M ForanTalha BadarJeanne M PalmerLisa SproatCecilia Y Arana YiAnimesh D PardananiAyalew TefferiPublished in: American journal of hematology (2022)
Keyphrases